The Access to COVID-19 Tools Accelerator (ACT-A) is a global collaboration to accelerate the development, production, and equitable access to COVID-19 tools (diagnostics, therapeutics, and vaccines). The ACT-A comprises four technical partnerships: three vertical pillars (vaccines, therapeutics and diagnostics) and one transversal Health Systems and Response Connector (HSRC).
The ACT-A HSRC is a multi-organization partnership that includes diverse stakeholders as its members. The ACT-A HSRC, co-led by the WHO, UNICEF, Global Fund, and World Bank with support from the Global Financing Facility (GFF), coordinates three key workstreams to support partner organizations and countries on critical aspects relating to uptake of COVID-19 tools.
Through close collaboration with partners, the ACT-A HSRC aims to enhance uptake of COVID-19 tools by supporting countries identify needs and gaps, coordinating with partners to address identified bottlenecks, and closely monitoring country progress against global targets.